Bentham Science Logo

Track Your Manuscript:


CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 20, 10 Issues, 2021
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Subscribe to this Journal

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

CNS & Neurological Disorders - Drug Targets , Volume 17 - Number 1


Preface   Open Access


Commentary   Open Access

Commentary: Let the Time Fly: Dopamine is the Arbiter

, 17(1): 3 - 5

Xiaodong Liu, Changzheng Zhang, Oscar Arias-Carrion* and Ti-Fei Yuan*


DOI: 10.2174/1871527316999170505110106




Review Article

Antidepressant Potential of Peptides: New Insights as Future Therapeutic

, 17(1): 9 - 13

Haroon Khan*, Sumaira Khattak, Mohammad S. Mubarak, Saud S. Bawazeer, Tareq Abu-Izneid and Mohammad A. Kamal


DOI: 10.2174/1871527316666170731102237



Review Article

C-Abl Inhibition; A Novel Therapeutic Target for Parkinson's Disease

, 17(1): 14 - 21

Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M. Hammad, Ahmed Menshawy and Wael M.Y. Mohamed


DOI: 10.2174/1871527316666170602101538



Review Article

VaD - An Integrated Framework for Cognitive Rehabilitation

, 17(1): 22 - 33

Maria Balea, Dafin Muresanu*, Anton Alvarez, Volker Homberg, Ovidiu Bajenaru, Alla Guekht, Wolf-Dieter Heiss, Livia Popa, Johannes Vester, Ioana Muresanu, Codruta Birle and Dana Slavoaca


DOI: 10.2174/1871527317666180219164545



Review Article

Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models

, 17(1): 34 - 42

Ana Carolina Bombardi Duarte, Maycon Giovani Santana, Guilherme di Camilo Orfali, Carlos Tadeu Parisi de Oliveira and Denise Goncalves Priolli*


DOI: 10.2174/1871527317666171221110139



Research Article

Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer’s Disease: in vitro and ex vivo Characterization

, 17(1): 43 - 53

Lupe C. Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria-Jose Fabrega and Ana C. Calpena


DOI: 10.2174/1871527317666180104122347



Research Article

In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease

, 17(1): 54 - 68

Kanzal Iman, Muhammad Usman Mirza*, Nauman Mazhar, Michiel Vanmeert, Imran Irshad and Mohammad A. Kamal


DOI: 10.2174/1871527317666180115162422



Research Article

TNF-α Polymorphisms and Maternal Depression in a Mexican Mestizo Population

, 17(1): 69 - 74

Ada Sandoval-Carrillo, Cosme Alvarado-Esquivel, Carlos Salas-Martinez, Edna M. Mendez-Hernandez, Antonio Sifuentes-Alvarez, Ana L. Martínez-Martinez, Juan M. Castillo-Orona, Jesus Hernandez-Tinoco, Elizabeth I. Antuna-Salcido, Luis F. Sanchez-Anguiano, Lilia M. Velez Velez, Sergio M. Salas-Pacheco, Francisco X. Castellanos-Juarez, Osmel La Llave-Leon, Oscar Arias-Carrion* and Jose M. Salas-Pacheco*


DOI: 10.2174/1871527317666180207165238




Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Scopus CiteScore Metrics: 2.72

Advertisement

CITATION BOOSTER

Related Journals

Related eBooks

eBooks Catalog